![]() |
市場調査レポート
商品コード
1510377
皮膚灌流圧(SPP)検査デバイスの市場規模、シェア、成長分析:製品タイプ別、モビリティ別、エンドユーザー別、地域別 - 産業予測、2024-2031年Skin Perfusion Pressure Testing Devices Market Size, Share, Growth Analysis, By Product Type, By Mobility, By End user, By Region - Industry Forecast 2024-2031 |
||||||
|
皮膚灌流圧(SPP)検査デバイスの市場規模、シェア、成長分析:製品タイプ別、モビリティ別、エンドユーザー別、地域別 - 産業予測、2024-2031年 |
出版日: 2024年07月05日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
皮膚灌流圧(SPP)検査デバイスの市場規模は2022年に14億3,000万米ドルと評価され、2023年の15億4,000万米ドルから2031年には27億8,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは7.65%で成長する見通しです。
SPP検査デバイスの世界市場は、いくつかの重要な要因によって一貫した成長を遂げています。末梢動脈疾患(PAD)や糖尿病などの血管疾患の有病率の増加により、非侵襲的な診断ツールに対する需要が高まっており、SPP検査デバイスは早期発見と継続的なモニタリングに欠かせないものとなっています。さらに、人口の高齢化と慢性的な健康状態の発生率の上昇が、市場の拡大をさらに刺激しています。これらの機器の精度と使いやすさを向上させる技術の進歩も、採用に拍車をかけています。医療システムは予防医療と患者の予後改善に重点を置いており、SPP検査デバイス市場は当面成長軌道を維持すると予想されます。
Skin Perfusion Pressure Testing Devices Market size was valued at USD 1.43 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 2.78 billion by 2031, growing at a CAGR of 7.65% during the forecast period (2024-2031).
The global market for skin perfusion pressure testing devices has experienced consistent growth driven by several key factors. Increased prevalence of vascular diseases like peripheral artery disease (PAD) and diabetes has heightened demand for non-invasive diagnostic tools, making skin perfusion pressure testing devices crucial for early detection and ongoing monitoring. Furthermore, an aging population and rising incidence of chronic health conditions have further stimulated market expansion. Technological advancements that enhance the accuracy and usability of these devices have also spurred adoption. With healthcare systems emphasizing preventive care and better patient outcomes, the market for skin perfusion pressure testing devices is expected to continue its growth trajectory in the foreseeable future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Skin Perfusion Pressure Testing Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Skin Perfusion Pressure Testing Devices Market Segmental Analysis
Skin perfusion pressure testing devices market can be segmented into product type, mobility, end user, and region. Based on product type, the market is segmented into Ultrasound Skin Perfusion Pressure Testing Device, Laser Doppler Skin Perfusion Pressure Testing Devices, and Photoplethysmography Skin Perfusion Pressure Testing Devices. Based on mobility, the market is segmented into Cart-based Devices, and Portable Devices. Based on end user, the market is segmented into Hospitals, Ambulance surgical center, Diagnostic Centers, and others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Drivers of the Skin Perfusion Pressure Testing Devices Market
The rising prevalence of peripheral vascular diseases, including conditions like peripheral artery disease (PAD) and diabetes, is a key catalyst for the global market of skin perfusion pressure testing devices. These diseases often result in compromised blood flow to the extremities, necessitating the use of non-invasive diagnostic tools such as skin perfusion pressure testing devices for early detection and treatment. Concurrently, ongoing advancements in medical technology, particularly in vascular diagnostics, are driving the adoption of more efficient and precise devices. These innovations improve the accuracy of diagnostic outcomes, making them increasingly appealing to healthcare providers and institutions.
Restraints in the Skin Perfusion Pressure Testing Devices Market
The high upfront expense associated with acquiring skin perfusion pressure testing devices presents a significant barrier for healthcare institutions, especially those in resource-limited environments, potentially restricting their widespread adoption and accessibility. Moreover, insufficient awareness among healthcare professionals about the advantages and proper utilization of these devices, coupled with the requirement for specialized training, poses another challenge. This lack of knowledge and training could result in underutilization of the devices, impeding their potential for market growth.
Market Trends of the Skin Perfusion Pressure Testing Devices Market
The rising prevalence of Peripheral Artery Disease (PAD), often associated with lifestyle factors like diabetes and obesity, is fueling demand for skin perfusion pressure testing devices. These devices play a crucial role in diagnosing and monitoring PAD, facilitating early intervention and improving patient outcomes. Concurrently, ongoing technological advancements are reshaping the market by introducing more precise and user-friendly options, such as handheld and portable devices. These innovations aim to enhance testing efficiency and accessibility across diverse clinical settings. Additionally, there is a growing trend of integrating these devices with telemedicine solutions, enabling remote patient monitoring for vascular conditions. This integration supports timely intervention and reduces the necessity for frequent in-person healthcare visits, particularly relevant amidst the COVID-19 pandemic.